XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (1,324,568) $ (2,935,708)
Net loss from discontinued operations 80,451
Net loss from continuing operations (1,324,568) (2,855,257)
Adjustments to reconcile net loss from continuing operations to net cash provided by (used in) operating activities:    
Amortization of intangible assets 1,602,053 616,750
Amortization of operating lease right-of-use assets 415,661 62,684
Depreciation of property and equipment 380,182
Deferred tax liability 99,881 (88,176)
Income tax liability (2,321,316) (14,072)
Stock-based compensation 289,305 124,130
Allowance for credit losses 3,436
Changes in operating assets and liabilities, net of acquired assets and disposition:    
Accounts receivable 2,136,524
Operating lease liabilities (416,523) (62,684)
Employee retention tax credit receivable, net 114,212  
Prepaid expense and other current assets (1,164,283) 454,696
Accounts payable, accrued expenses and other current liabilities 1,682,770 812,256
Deferred revenue (508,192) 25,045
Net cash provided by (used in) operating activities – continuing operations 989,142 (924,628)
Net cash used in operating activities –discontinued operations (627,108)
Net cash provided by (used in) operating activities 989,142 (1,551,736)
Cash flows from investing activities:    
Cash paid for acquisition of NTS (4,000,000)
Purchases of fixed assets (280,149)  
Net cash used in investing activities (4,280,149)
Cash flows from financing activities:    
Proceeds from sale of Transferred Assets 1,350,000
Purchase of treasury stock (301,048)
Proceeds from exercise of employee stock options 39,772
Net cash provided by financing activities 1,048,952 39,772
Net decrease in cash and cash equivalents (2,242,055) (1,511,964)
Balance of cash and cash equivalents at beginning of period 10,588,534 13,568,049
Balance of cash and cash equivalents at end of period, including restricted cash of $1,025,176 at September 30, 2025 8,346,479 12,056,085
Supplemental non-cash disclosure:    
Non-cash portion of consideration for acquisition of NTS (Series A Preferred Stock issuance) $ 8,200,000